Did Your Physician Tell You Why the FDA Put Celexa in Category C?
For years, the Food and Drug Administration (FDA) has warned physicians and patients against the risks of taking a certain class of antidepressants – collectively known as selective serotonin reuptake inhibitors (SSRIs) – during pregnancy. In fact, the FDA has so forceful in its efforts to appropriately warn the public that it has placed Celexa (citalopram) and other SSRI drugs in Pregnancy Category C.
By place Celexa (citalopram) in Pregnancy Category C, the FDA cautions that Celexa (citalopram) may cause serious lung problems in newborns if their mother took Celexa during pregnancy. Breastfeeding is also a source of potential risk. Moreover, the FDA clearly and definitively advises that women who are pregnant or may become pregnant should consult with their physician.
Are you a Celexa patient who recently gave birth and didn’t hear these warnings or hear them with this level of force? Unfortunately, that’s not really a surprise. For even longer than the FDA has been warning physicians and patients, drug manufacturers have worked to soft sell the risks associated with their product. Who has paid the price? Mothers, children, and families just like yours.
Want to know whether you or your injured child is entitled to a legal recovery from the makers of Celexa? The answer to this question and many, many others is just a phone call away. Contact the dangerous drug experts at Fears Nachawati today! For your free consultation, call us at 1.866.545.8364 or email firstname.lastname@example.org.